Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S.-EU MRA negotiators to address outstanding questions at mid-May meeting.

This article was originally published in The Tan Sheet

Executive Summary

U.S.-EU MRA NEGOTIATORS LOOK TO RESOLVE OUTSTANDING ISSUES IN MID-MAY, prior to a U.S.-EU summit in the Hague scheduled for May 28. FDA negotiators have asked for face-to-face meetings in Washington, D.C. in mid-May, following a teleconference set for the week of May 5. A meeting has not yet been scheduled, but FDA and EU Commission negotiators appear to have been making headway on the details of a mutual recognition agreement on Good Manufacturing Practices through a series of teleconferences over the past two months.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087013

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel